A QSAR model of HERG binding using a large, diverse, and internally consistent training set

Chemical Biology & Drug Design
Mark Seierstad, Dimitris K Agrafiotis

Abstract

Over the past decade, the pharmaceutical industry has begun to address an addition to ADME/Tox profiling--the ability of a compound to bind to and inhibit the human ether-a-go-go-related gene (hERG)-encoded cardiac potassium channel. With the compilation of a large and diverse set of compounds measured in a single, consistent hERG channel inhibition assay, we recognized a unique opportunity to attempt to construct predictive QSAR models. Early efforts with classification models built from this training set were very encouraging. Here, we report a systematic evaluation of regression models based on neural network ensembles in conjunction with a variety of structure representations and feature selection algorithms. The combination of these modeling techniques (neural networks to capture non-linear relationships in the data, feature selection to prevent over-fitting, and aggregation to minimize model instability) was found to produce models with very good internal cross-validation statistics and good predictivity on external data.

References

Oct 28, 1994·Journal of Medicinal Chemistry·D T ManallackD J Livingstone
Mar 1, 1997·Journal of Chemical Information and Computer Sciences·K HasegawaK Funatsu
Jan 6, 2001·Journal of Molecular Graphics & Modelling·D N Rassokhin, D K Agrafiotis
Feb 24, 2001·Journal of Chemical Information and Computer Sciences·S Izrailev, D Agrafiotis
Oct 18, 2001·Journal of Chemical Information and Computer Sciences·A Yasri, D Hartsough
Feb 22, 2002·Journal of Medicinal Chemistry·Dimitris K Agrafiotis, Walter Cedeño
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Sean EkinsSteven A Wrighton
Jul 18, 2002·Nature Reviews. Drug Discovery·Dimitris K AgrafiotisF Raymond Salemme
Jul 23, 2002·Journal of Chemical Information and Computer Sciences·Dimitris K AgrafiotisVictor S Lobanov
Aug 20, 2002·SAR and QSAR in Environmental Research·S Izrailev, D K Agrafiotis
Nov 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Dimitris K Agrafiotis, Huafeng Xu
Mar 26, 2003·Journal of Chemical Information and Computer Sciences·Dimitris K Agrafiotis, Huafeng Xu
May 6, 2003·Bioorganic & Medicinal Chemistry Letters·Robert A PearlsteinDavid Rampe
May 30, 2003·Biochemical Society Transactions·S Ekins
Jun 24, 2003·Journal of Computational Chemistry·Dimitris K Agrafiotis
Jul 23, 2003·Bioorganic & Medicinal Chemistry Letters·György M Keserü
Sep 19, 2003·Journal of Computer-aided Molecular Design·Walter Cedeño, Dimitris K Agrafiotis
Apr 15, 2004·Bioorganic & Medicinal Chemistry·Alex M Aronov, Brian B Goldman
Apr 28, 2004·Cell Calcium·A M Brown
May 25, 2004·Journal of Chemical Information and Computer Sciences·Evgeny Byvatov, Gisbert Schneider
Aug 4, 2004·Progress in Biophysics and Molecular Biology·William BainsCat White
Feb 18, 2005·Journal of Medicinal Chemistry·Sean E O'Brien, Marcel J de Groot
Mar 5, 2005·Bioorganic & Medicinal Chemistry Letters·Ramkumar RajamaniCharles H Reynolds
Mar 8, 2005·Trends in Pharmacological Sciences·Michael C Sanguinetti, John S Mitcheson
May 25, 2005·Bioorganic & Medicinal Chemistry Letters·Motoi TobitaRenpei Nagashima
Jun 28, 2005·Bioorganic & Medicinal Chemistry Letters·Giovanni CianchettaRoy J Vaz
Jan 24, 2006·Journal of Chemical Information and Modeling·Minghu Song, Matthew Clark
May 13, 1983·Science·S KirkpatrickM P Vecchi

❮ Previous
Next ❯

Citations

Mar 4, 2008·SAR and QSAR in Environmental Research·O FilzV Poroikov
Oct 23, 2013·Chemistry Central Journal·Clayton Springer, Katherine L Sokolnicki
May 15, 2010·Expert Opinion on Drug Metabolism & Toxicology·Anthony E Klon
Jul 4, 2009·Expert Opinion on Drug Metabolism & Toxicology·Emanuel RaschiMaurizio Recanatini
Mar 17, 2015·Advanced Drug Delivery Reviews·Bruno O Villoutreix, Olivier Taboureau
Jun 29, 2007·Bioorganic & Medicinal Chemistry·Stephen R JohnsonPaul Levesque
Sep 4, 2015·Quarterly Reviews of Biophysics·Yulan WangHualiang Jiang
Oct 11, 2008·Chemical Biology & Drug Design·Khac-Minh Thai, Gerhard F Ecker
Dec 7, 2007·ChemMedChem·Christian KramerTimothy Clark
Jun 22, 2007·Chemical Biology & Drug Design·Bahram HemmateenejadAbbas Shafiee
Sep 1, 2012·Molecular Informatics·Zhi WangAixia Yan
Apr 14, 2016·Toxicology Letters·Marco GobbiMario Salmona
Jan 7, 2015·Journal of Applied Toxicology : JAT·Barbara WiśniowskaSebastian Polak
Apr 18, 2014·Journal of Medicinal Chemistry·Christian KramerKlaus R Liedl
Nov 1, 2011·Journal of Chemical Information and Modeling·Michael D HackDimitris K Agrafiotis
Mar 23, 2012·Journal of Chemical Information and Modeling·Thomas SciorDimitris K Agrafiotis
Aug 8, 2013·Journal of Medicinal Chemistry·Scot MenteTravis Wager
Jul 1, 2014·Acta Pharmacologica Sinica·Li-li LiuKai-xian Chen
Sep 20, 2012·Physiological Reviews·Jamie I VandenbergAdam P Hill
May 13, 2009·Journal of Chemical Information and Modeling·Britta Nisius, Andreas H Göller
Nov 10, 2009·Journal of Chemical Information and Modeling·Matthew Clark, Jeffrey S Wiseman
Jun 23, 2010·Journal of Chemical Information and Modeling·Bo-Han SuYufeng J Tseng
May 19, 2018·Journal of Chemical Information and Modeling·Vishal B SiramshettyRobert Preissner
Sep 11, 2021·Journal of Chemical Information and Modeling·Teresa Maria CreanzaGiuseppe Felice Mangiatordi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved